...
【24h】

Response

机译:响应

获取原文
获取原文并翻译 | 示例
           

摘要

We have read with great interest the comments of Lim on our paper and on the findings of Gold et al. and Kolb et al. They pointed out the most common doubts, questions, and opinions about the clinical advantages and disadvantages of defibrillation threshold testing (DFT) during implantable cardioverter-defibrillator (ICD) implantation.International guidelines report that the strongest indicator to an ICD implantation is the left ventricular (LV) function, commonly evaluated by the left ventricular ejection fraction (LVEF) measurement, which is considered as a powerful predictor of death.
机译:我们非常感兴趣地阅读了Lim在论文和Gold等人的发现中的评论。和Kolb等。他们指出了在植入式心脏复律除颤器(ICD)植入过程中除颤阈值测试(DFT)的临床优缺点的最常见疑问,疑问和意见。国际指南报告说,ICD植入最强的指标是左心室(LV)功能,通常通过左心室射血分数(LVEF)测量来评估,这被认为是死亡的有力预测指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号